- Startseite
- Aktien
- Company regulated news
Company press releases
Released | Company | Title | Industry | Topic |
---|---|---|---|---|
23 Apr 2024 08:00 CEST |
TME PHARMA | TME PHARMA ANNONCE QUE 33% DES PATIENTS AYANT REÇU LE NOX-A12 EN COMBINAISON AVEC LE BEVACIZUMAB ET LA RADIOTHÉRAPIE ONT ATTEINT DEUX ANS DE SURVIE DANS L'ESSAI DE PHASE 1/2 GLORIA DANS LE CANCER DU CERVEAU | 20103010 Biotechnology | Other subject |
23 Apr 2024 08:00 CEST |
ABL GROUP ASA | ABL Group ASA: Transactions made under share buyback program | 50205020 Professional Business Support Services | Acquisition or disposal of the issuer’s own shares |
23 Apr 2024 08:00 CEST |
CAPSOL TECHNOLOGIES ASA | Capsol Technologies ASA – Notice of Annual General Meeting 2024 | 50202020 Electronic Equipment: Control and Filter | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2024 08:00 CEST |
LEGRAND | Legrand poursuit ses investissements dans les segments porteurs | 50202010 Electrical Components | Mergers, Acquiqitions, Transferts |
23 Apr 2024 08:00 CEST |
NOVACYT | Plan d'Intéressement à Long Terme | 20102010 Medical Equipment | Legal |
23 Apr 2024 08:00 CEST |
WERELDHAVE BELGIUM | Trading update 31 mars 2024 | 35102045 Retail REITs | New |
23 Apr 2024 08:00 CEST |
GROUPE AIRWELL | LANDMARK 2023 FINANCIAL YEAR FOR AIRWELL: RECORD 2023 REVENUE: EUR 65.0M - EBITDA MARGIN: 4.8%, IN LINE WITH THE TARGET - SOUND FINANCIAL STRUCTURE | 40202020 Household Appliance | Sales, Income, Commercial results |
23 Apr 2024 08:00 CEST |
KBC | KBC Groep: Update m.b.t. inkoopprogramma van KBC Groep voor eigen aandelen | 30101010 Banks | Other subject |
23 Apr 2024 08:00 CEST |
TME PHARMA | TME Pharma Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two‑Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer | 20103010 Biotechnology | Other subject |
23 Apr 2024 08:00 CEST |
KBC | KBC Group: Update regarding the KBC Group share buyback programme | 30101010 Banks | Other subject |
23 Apr 2024 08:00 CEST |
Tysnes Sparebank | Innkalling til forstandarskapsmøte i Tysnes Sparebank | - | Annen informasjonspliktig regulatorisk informasjon |
23 Apr 2024 08:00 CEST |
LEGRAND | Legrand pursues its investments in buoyant segments | 50202010 Electrical Components | Mergers, Acquiqitions, Transferts |
23 Apr 2024 08:00 CEST |
BENCHMARK HOLDINGS PLC | Rule 2.9 Announcement | 20103010 Biotechnology | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2024 08:00 CEST |
WERELDHAVE BELGIUM | Trading update 31 maart 2024 | 35102045 Retail REITs | New |
23 Apr 2024 08:00 CEST |
NOVACYT | Long Term Incentive Plan | 20102010 Medical Equipment | Legal |
23 Apr 2024 08:00 CEST |
WERELDHAVE BELGIUM | Trading update 31 March 2024 | 35102045 Retail REITs | New |
23 Apr 2024 08:00 CEST |
GROUPE AIRWELL | UN EXERCICE 2023 HISTORIQUE POUR AIRWELL : CHIFFRE D'AFFAIRES 2023 RECORD : 65,0 M EUR - MARGE D'EBITDA : 4,8%, EN LIGNE AVEC L'OBJECTIF - UNE STRUCTURE FINANCIÈRE SAINE | 40202020 Household Appliance | Sales, Income, Commercial results |
23 Apr 2024 07:59 CEST |
PANORO ENERGY | Panoro Energy - Rig Secured to Recommence Drilling Offshore Equatorial Guinea | 60101010 Oil: Crude Producers | Inside information |
23 Apr 2024 07:57 CEST |
GOLDEN ENERGY OFFSHORE SERVICES | Mandatory notification of trade | 60101030 Oil Equipment and Services | Mandatory notification of trade primary insiders |
23 Apr 2024 07:45 CEST |
BOLIDEN AB | Boliden's Q1 2024: Key investment decisions in a challenging quarter | 55102000 General Mining | Half yearly financial reports and audit reports/limited reviews |
23 Apr 2024 07:45 CEST |
BOLIDEN AB | Bolidens Q1 2024: Viktiga investeringsbeslut under ett utmanande kvartal | 55102000 General Mining | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
23 Apr 2024 07:45 CEST |
LARGO | Largo publie ses résultats annuels 2023 et son chiffre d’affaires du premier trimestre 2024 | 10102030 Computer Hardware | Other subject |
23 Apr 2024 07:37 CEST |
DNB Boligkreditt AS | 1. kvartals rapport 2024 fra DNB Boligkreditt AS | - | Annen informasjonspliktig regulatorisk informasjon |
23 Apr 2024 07:37 CEST |
DNB Boligkreditt AS | First quarter report 2024 from DNB Boligkreditt AS | - | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2024 07:31 CEST |
SpareBank 1 Nord-Norge | SpareBank 1 Gruppen – resultat 1. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
23 Apr 2024 07:31 CEST |
SpareBank 1 Nord-Norge | SpareBank 1 Gruppen – Q1 2024 Results | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2024 07:31 CEST |
DNB BANK ASA | Sterk fondsvekst og økt fart i boligmarkedet og blant bedrifter | 30101010 Banks | Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll |
23 Apr 2024 07:31 CEST |
DNB BANK ASA | Strong growth in mutual funds and increased momentum in the housing market and among businesses | 30101010 Banks | Half yearly financial reports and audit reports/limited reviews |
23 Apr 2024 07:30 CEST |
SPAREBANK 1 HELGELAND | SpareBank 1 Gruppen – Q1 2024 Results | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2024 07:30 CEST |
GIGANTE SALMON AS | Gigante Salmon AS: Update on financing | 45102010 Farming, Fishing, Ranching and Plantations | Inside information |
23 Apr 2024 07:30 CEST |
SPAREBANK 1 SØRØST-NORGE | SpareBank 1 Gruppen – resultat 1. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
23 Apr 2024 07:30 CEST |
THERANEXUS | Theranexus, Diverchim et l'INSERM bénéficient d'un financement de 4.7 millions d'euros dans le cadre de l'appel à projets " Innovations en Biothérapies et Bioproduction " de France 2030, pour développer un nouvel oligonucléotide antisens | 20103010 Biotechnology | Legal |
23 Apr 2024 07:30 CEST |
GIGANTE SALMON AS | Gigante Salmon AS: New CEO and Chairperson - Changes in management and the board of directors | 45102010 Farming, Fishing, Ranching and Plantations | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2024 07:30 CEST |
SpareBank 1 Ringerike Hadeland | SpareBank 1 Ringerike Hadeland (RING): SpareBank 1 Gruppen – resultat 1. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
23 Apr 2024 07:30 CEST |
THERAVET | TheraVet reports Full-Year 2023 Financial Results and Provides the Preparatory Documents for the General Meeting of June 6th, 2024 | 20103015 Pharmaceuticals | Income |
23 Apr 2024 07:30 CEST |
SpareBank 1 SR-Bank ASA | SpareBank 1 Gruppen – Q1 2024 Results | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2024 07:30 CEST |
SpareBank 1 Østlandet | SpareBank 1 Østlandet (SPOL): SpareBank 1 Gruppen – resultat 1. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
23 Apr 2024 07:30 CEST |
Boussard Gavaudan | BGHL (EUR): NAV(s) | 30204000 Closed End Investments | Other subject |
23 Apr 2024 07:30 CEST |
EAM SOLAR | EAM Solar ASA: Invitation to an information meeting on Friday 3 May at 11:00 | 30202000 Diversified Financial Services | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2024 07:30 CEST |
SpareBank 1 SMN | SpareBank 1 Gruppen – resultat 1. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
23 Apr 2024 07:30 CEST |
GIGANTE SALMON AS | Gigante Salmon AS: Publisering av kvartalsrapport Q1 | 45102010 Farming, Fishing, Ranching and Plantations | Innsideinformasjon |
23 Apr 2024 07:30 CEST |
SpareBank 1 Nordmøre | SpareBank 1 Gruppen – resultat 1. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
23 Apr 2024 07:30 CEST |
SPAREBANK 1 SØRØST-NORGE | SpareBank 1 Gruppen – Q1 2024 Results | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2024 07:30 CEST |
THERANEXUS | Theranexus, Diverchim and Inserm awarded EUR 4.7 million in funding under the "Innovations in biotherapies and biomanufacturing" call for proposals from France 2030 to develop a novel antisense oligonucleotide | 20103010 Biotechnology | Legal |
23 Apr 2024 07:30 CEST |
GIGANTE SALMON AS | Gigante Salmon AS: Oppdatering på finansiering | 45102010 Farming, Fishing, Ranching and Plantations | Innsideinformasjon |
23 Apr 2024 07:30 CEST |
SpareBank 1 Østfold Akershus | SpareBank 1 Østfold Akershus: SpareBank 1 Gruppen – resultat 1. kvartal 2024 | 30101010 Banks | Annen informasjonspliktig regulatorisk informasjon |
23 Apr 2024 07:30 CEST |
THERAVET | TheraVet publie ses résultats annuels pour l’exercice 2023 et met à disposition les documents préparatoires pour l’Assemblée Générale du 6 juin 2024 | 20103015 Pharmaceuticals | Income |
23 Apr 2024 07:30 CEST |
GIGANTE SALMON AS | Gigante Salmon AS: Administrerende direktør og styreleder – Endring i ledelse og styre | 45102010 Farming, Fishing, Ranching and Plantations | Annen informasjonspliktig regulatorisk informasjon |
23 Apr 2024 07:30 CEST |
SpareBank 1 Østlandet | SpareBank 1 Østlandet (SPOL): SpareBank 1 Gruppen – Q1 2024 results | 30101010 Banks | Additional regulated information required to be disclosed under the laws of a Member State |
23 Apr 2024 07:30 CEST |
BOUSSARD GAVAUDAN HOLD LTD GBP | BGHL (GBP): NAV(s) | 30204000 Closed End Investments | Other subject |